# Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

> **NCT00587574** · — · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 150 (estimated)

## Conditions studied

- Allogeneic Hematopoietic Cell Transplant Recipients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00587574
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587574, "Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00587574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*